206 related articles for article (PubMed ID: 32603404)
1. Interplay between estrogen and Stat3/NF-κB-driven immunomodulation in lung cancer.
Deng S; Ramos-Castaneda M; Velasco WV; Clowers MJ; Gutierrez BA; Noble O; Dong Y; Zarghooni M; Alvarado L; Caetano MS; Yang S; Ostrin EJ; Behrens C; Wistuba II; Stabile LP; Kadara H; Watowich SS; Moghaddam SJ
Carcinogenesis; 2020 Nov; 41(11):1529-1542. PubMed ID: 32603404
[TBL] [Abstract][Full Text] [Related]
2. Sex specific function of epithelial STAT3 signaling in pathogenesis of K-ras mutant lung cancer.
Caetano MS; Hassane M; Van HT; Bugarin E; Cumpian AM; McDowell CL; Cavazos CG; Zhang H; Deng S; Diao L; Wang J; Evans SE; Behrens C; Wistuba II; Fuqua SAW; Lin H; Stabile LP; Watowich SS; Kadara H; Moghaddam SJ
Nat Commun; 2018 Nov; 9(1):4589. PubMed ID: 30389925
[TBL] [Abstract][Full Text] [Related]
3. IL6 Blockade Reprograms the Lung Tumor Microenvironment to Limit the Development and Progression of K-ras-Mutant Lung Cancer.
Caetano MS; Zhang H; Cumpian AM; Gong L; Unver N; Ostrin EJ; Daliri S; Chang SH; Ochoa CE; Hanash S; Behrens C; Wistuba II; Sternberg C; Kadara H; Ferreira CG; Watowich SS; Moghaddam SJ
Cancer Res; 2016 Jun; 76(11):3189-99. PubMed ID: 27197187
[TBL] [Abstract][Full Text] [Related]
4. IL22 Promotes
Khosravi N; Caetano MS; Cumpian AM; Unver N; De la Garza Ramos C; Noble O; Daliri S; Hernandez BJ; Gutierrez BA; Evans SE; Hanash S; Alekseev AM; Yang Y; Chang SH; Nurieva R; Kadara H; Chen J; Ostrin EJ; Moghaddam SJ
Cancer Immunol Res; 2018 Jul; 6(7):788-797. PubMed ID: 29764837
[TBL] [Abstract][Full Text] [Related]
5. Macrophages promote benzopyrene-induced tumor transformation of human bronchial epithelial cells by activation of NF-κB and STAT3 signaling in a bionic airway chip culture and in animal models.
Li E; Xu Z; Zhao H; Sun Z; Wang L; Guo Z; Zhao Y; Gao Z; Wang Q
Oncotarget; 2015 Apr; 6(11):8900-13. PubMed ID: 25823926
[TBL] [Abstract][Full Text] [Related]
6. Disruption of STAT3 signalling promotes KRAS-induced lung tumorigenesis.
Grabner B; Schramek D; Mueller KM; Moll HP; Svinka J; Hoffmann T; Bauer E; Blaas L; Hruschka N; Zboray K; Stiedl P; Nivarthi H; Bogner E; Gruber W; Mohr T; Zwick RH; Kenner L; Poli V; Aberger F; Stoiber D; Egger G; Esterbauer H; Zuber J; Moriggl R; Eferl R; Győrffy B; Penninger JM; Popper H; Casanova E
Nat Commun; 2015 Mar; 6():6285. PubMed ID: 25734337
[TBL] [Abstract][Full Text] [Related]
7. Targeting IL-1β as an immunopreventive and therapeutic modality for K-ras-mutant lung cancer.
Yuan B; Clowers MJ; Velasco WV; Peng S; Peng Q; Shi Y; Ramos-Castaneda M; Zarghooni M; Yang S; Babcock RL; Chang SH; Heymach JV; Zhang J; Ostrin EJ; Watowich SS; Kadara H; Moghaddam SJ
JCI Insight; 2022 Jun; 7(11):. PubMed ID: 35471938
[TBL] [Abstract][Full Text] [Related]
8. Requirement of the NF-kappaB subunit p65/RelA for K-Ras-induced lung tumorigenesis.
Bassères DS; Ebbs A; Levantini E; Baldwin AS
Cancer Res; 2010 May; 70(9):3537-46. PubMed ID: 20406971
[TBL] [Abstract][Full Text] [Related]
9. Differential roles of STAT3 in the initiation and growth of lung cancer.
Zhou J; Qu Z; Yan S; Sun F; Whitsett JA; Shapiro SD; Xiao G
Oncogene; 2015 Jul; 34(29):3804-3814. PubMed ID: 25284582
[TBL] [Abstract][Full Text] [Related]
10. Roles of Pin1 as a Key Molecule for EMT Induction by Activation of STAT3 and NF-κB in Human Gallbladder Cancer.
Nakada S; Kuboki S; Nojima H; Yoshitomi H; Furukawa K; Takayashiki T; Takano S; Miyazaki M; Ohtsuka M
Ann Surg Oncol; 2019 Mar; 26(3):907-917. PubMed ID: 30610554
[TBL] [Abstract][Full Text] [Related]
11. Mutations of p53 and KRAS activate NF-κB to promote chemoresistance and tumorigenesis via dysregulation of cell cycle and suppression of apoptosis in lung cancer cells.
Yang L; Zhou Y; Li Y; Zhou J; Wu Y; Cui Y; Yang G; Hong Y
Cancer Lett; 2015 Feb; 357(2):520-6. PubMed ID: 25499080
[TBL] [Abstract][Full Text] [Related]
12. Aerosol delivery of lentivirus-mediated O-glycosylation mutant osteopontin suppresses lung tumorigenesis in K-ras (LA1) mice.
Minai-Tehrani A; Chang SH; Kwon JT; Hwang SK; Kim JE; Shin JY; Yu KN; Park SJ; Jiang HL; Kim JH; Hong SH; Kang B; Kim D; Chae CH; Lee KH; Beck GR; Cho MH
Cell Oncol (Dordr); 2013 Feb; 36(1):15-26. PubMed ID: 23070870
[TBL] [Abstract][Full Text] [Related]
13. Rig-G is a growth inhibitory factor of lung cancer cells that suppresses STAT3 and NF-κB.
Li D; Sun J; Liu W; Wang X; Bals R; Wu J; Quan W; Yao Y; Zhang Y; Zhou H; Wu K
Oncotarget; 2016 Oct; 7(40):66032-66050. PubMed ID: 27602766
[TBL] [Abstract][Full Text] [Related]
14. MALT1 is required for EGFR-induced NF-κB activation and contributes to EGFR-driven lung cancer progression.
Pan D; Jiang C; Ma Z; Blonska M; You MJ; Lin X
Oncogene; 2016 Feb; 35(7):919-28. PubMed ID: 25982276
[TBL] [Abstract][Full Text] [Related]
15. Epithelial NF-kappaB activation promotes urethane-induced lung carcinogenesis.
Stathopoulos GT; Sherrill TP; Cheng DS; Scoggins RM; Han W; Polosukhin VV; Connelly L; Yull FE; Fingleton B; Blackwell TS
Proc Natl Acad Sci U S A; 2007 Nov; 104(47):18514-9. PubMed ID: 18000061
[TBL] [Abstract][Full Text] [Related]
16. Notopterol Suppresses IL-17-Induced Proliferation and Invasion of A549 Lung Adenocarcinoma Cells via Modulation of STAT3, NF-κB, and AP-1 Activation.
Inthanon S; Dejkriengkraikul P; Yodkeeree S
Int J Mol Sci; 2023 Oct; 24(20):. PubMed ID: 37894738
[TBL] [Abstract][Full Text] [Related]
17. UBE2S activates NF-κB signaling by binding with IκBα and promotes metastasis of lung adenocarcinoma cells.
Ho JY; Lu HY; Cheng HH; Kuo YC; Lee YA; Cheng CH
Cell Oncol (Dordr); 2021 Dec; 44(6):1325-1338. PubMed ID: 34582005
[TBL] [Abstract][Full Text] [Related]
18. Inhibitor of Differentiation-1 Sustains Mutant
Román M; López I; Guruceaga E; Baraibar I; Ecay M; Collantes M; Nadal E; Vallejo A; Cadenas S; Miguel ME; Jang JH; Martin-Uriz PS; Castro-Labrador L; Vilas-Zornoza A; Lara-Astiaso D; Ponz-Sarvise M; Rolfo C; Santos ES; Raez LE; Taverna S; Behrens C; Weder W; Wistuba II; Vicent S; Gil-Bazo I
Cancer Res; 2019 Feb; 79(3):625-638. PubMed ID: 30563891
[TBL] [Abstract][Full Text] [Related]
19. JAK-STAT inhibition impairs K-RAS-driven lung adenocarcinoma progression.
Mohrherr J; Haber M; Breitenecker K; Aigner P; Moritsch S; Voronin V; Eferl R; Moriggl R; Stoiber D; Győrffy B; Brcic L; László V; Döme B; Moldvay J; Dezső K; Bilban M; Popper H; Moll HP; Casanova E
Int J Cancer; 2019 Dec; 145(12):3376-3388. PubMed ID: 31407334
[TBL] [Abstract][Full Text] [Related]
20. CUEDC2 suppresses glioma tumorigenicity by inhibiting the activation of STAT3 and NF-κB signaling pathway.
Li F; Tang C; Jin D; Guan L; Wu Y; Liu X; Wu X; Wu QY; Gao D
Int J Oncol; 2017 Jul; 51(1):115-127. PubMed ID: 28534933
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
